Merck
MRK
#40
Rank
S$438.00 B
Marketcap
S$177.67
Share price
-3.90%
Change (1 day)
41.62%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): S$1.26

According to Merck's latest financial reports the company's current EPS (TTM) is S$1.28. In 2025 the company made an earnings per share (EPS) of S$9.43 an increase over its 2024 EPS that were of S$8.72.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$1.26-86.67%
2025S$9.438.15%
2024S$8.724308.46%
2023S$0.20-97.32%
2022S$7.3910.92%
2021S$6.6684.68%
2020S$3.61-27.2%
2019S$4.9563.44%
2018S$3.03151.11%
2017S$1.21-54.58%
2016S$2.6630.21%
2015S$2.04-61.99%
2014S$5.37180.51%
2013S$1.91-31.82%
2012S$2.816.62%
2011S$2.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.61 572.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.77 428.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.92-28.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$3.49 172.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.83 3,010.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$22.41 1,650.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.55 99.44%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$5.83 355.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$3.71 189.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$0.58-54.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel